Main Article Content
Hyperhidrosis is defined as an excessive sweating beyond what would be expected for thermoregulation. This condition can be categorized as idiopathic or secondary to a related disease. Facial hyperhidrosis, usually idiopathic, is rare affecting up to 10% of patients with focal hyperhidrosis. Authors present a rare presentation of a primary craniofacial hyperhidrosis. The aim of this study is to evaluate the characteristics of this pathology and treatment modalities through an interesting case report of a facial localization and a review of literature.
Stolman LP. Treatment of hyperhidrosis. Dermatol Clin. 1998;16(4):863‑9.
Campanelli A, Salomon D. Hyperhidrose localisée: Clinique et traitements. Rev Med Suisse. 2009;5:870-5.
Cohen JL, Cohen G, Solish N, Murray CA. Diagnosis, impact, and management of focal hyperhidrosis: Treatment review including botulinum toxin therapy. Facial Plast Surg Clin N Am. 2007;15(1):17‑30.
Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg. 1977;186(1):34‑41.
Strutton DR, Kowalski JW, PharmD, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey. J Am Acad Dermatol. 2004;51(2):241‑8.
Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ Can Med Assoc J J Assoc Medicale Can. 2005; 172(1):69‑75.
Schlereth T, Dieterich M, Birklein F. Hyperhidrosis - Causes and treatment of enhanced sweating. Dtsch Arzteblatt Int. 2009;106(3):32‑7.
Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: Evidence of genetic transmission. J Vasc Surg. 2002;35(2): 382‑6.
Hamm H, Naumann MK, Kowalski JW, Kütt S, Kozma C, Teale C. Primary focal hyperhidrosis: Disease characteristics and functional impairment. Dermatol Basel Switz. 2006;212(4):343‑53.
Grabell DA, Hebert AA. Current and Emerging Medical Therapies for Primary Hyperhidrosis. Dermatol Ther. 2017;7(1): 25‑36.
Hölzle E. Topical pharmacological treatment. Curr Probl Dermatol. 2002;30: 30‑43.
McConaghy JR, Fosselman D. Hyperhidrosis: Management options. Am Fam Physician. 2018;97(11):729‑34.
Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2002;28(6):495‑9.
D. Anders, Markus K. Naumann et al. Craniofacial hyperhidrosis successfully treated with botulinum toxin type A. Eur J Dermatol. 2008; 18(1):87-8.
Claes G: Indications for endoscopic thoracic sympathectomy. Clin Auton Res 2003;13(Suppl 1):I16–9.
Wollina U, Köstler E, Schönlebe J, Haroske G. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2008;34 (5):709‑16.
Budamakuntla L, Loganathan E, George A, Revanth B, Sankeerth V, Sarvjnamurthy SA. Comparative study of efficacy and safety of botulinum toxin a injections and subcutaneous curettage in the treatment of axillary hyperhidrosis. J Cutan Aesthetic Surg. 2017;10(1):33‑9.
Kurta AO and Glaser DA. Emerging nonsurgical treatments for hyperhidrosis. Thoracic Surgery Clinics. 2016;26(4):395–402.
Lupin M, Hong HC, O’Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg. 2014;40(7):805–7.
Abtahi-Naeini B, Naeini FF, Saffaei A, Behfar S, Pourazizi M, Mirmohammadkhani M, Bolandnazar NS. Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: Is it still effective after long-term follow-up? Indian J Dermatol. 2016;61(2):234.
Perez Rivera F. Pilot study for permanent resolution of axillary hyperhidrosis: elimination of sweat glands with intradermal microneedle radio-frequency. Eur J Plast Surg. 2019;42:161–168.
Nestor MS, Park H. Safety and efficacy of micro-focused ultrasound PLUS visualization for the treatment of axillary hyperhidrosis. J Clin Aesthet Dermatol. 2014;7(4):14–21.